The regulatory agencies in France, Switzerland, and France have issued warnings against the fraudulent use of products available online, which can be used for diagnosing, preventing infections associated with the SARS-CoV-2 Virus.
The alert shared by the Swiss Agency for Therapeutic Products (Swissmedic) highlighted online sales of chloroquine, a malaria drug with a similar chemical structure to hydroxychloroquine, as an area of concern.